PAVmed (NASDAQ:PAVM) Chairman Lishan Aklog acquired 2,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 23rd. The shares were bought at an average price of $8.98 per share, with a total value of $19,756.00. Following the completion of the purchase, the chairman now directly owns 25,600 shares in the company, valued at $229,888. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

Lishan Aklog also recently made the following trade(s):

  • On Monday, November 21st, Lishan Aklog acquired 2,300 shares of PAVmed stock. The shares were bought at an average price of $10.02 per share, with a total value of $23,046.00.
  • On Friday, September 16th, Lishan Aklog acquired 1,300 shares of PAVmed stock. The shares were bought at an average price of $14.05 per share, with a total value of $18,265.00.
  • On Wednesday, September 14th, Lishan Aklog acquired 1,500 shares of PAVmed stock. The shares were bought at an average price of $13.40 per share, with a total value of $20,100.00.

Shares of PAVmed (NASDAQ:PAVM) opened at 9.50 on Tuesday. The company’s 50 day moving average price is $11.06 and its 200-day moving average price is $12.79. PAVmed has a 52 week low of $8.71 and a 52 week high of $15.24. The stock’s market capitalization is $126.45 million.

ILLEGAL ACTIVITY NOTICE: “PAVmed (PAVM) Chairman Lishan Aklog Purchases 2,200 Shares of Stock” was reported by Financial Market News and is owned by of Financial Market News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of US & international trademark and copyright law. The correct version of this piece of content can be viewed at http://www.financial-market-news.com/pavmed-pavm-chairman-lishan-aklog-purchases-2200-shares-of-stock/1208144/.

5 Day Chart for NASDAQ:PAVM

Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.